Works matching IS 00071048 AND DT 2018 AND VI 182 AND IP 4


Results: 27
    1
    2

    Differential prognostic impact of GELTAMO‐IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 534, doi. 10.1111/bjh.15446
    By:
    • Montalbán, Carlos;
    • Díaz‐López, Antonio;
    • Martín, Alejandro;
    • Baile, Mónica;
    • Sanchez, José M.;
    • Sancho, Juan M.;
    • García, Olga;
    • Novelli, Silvana;
    • Monter‐Rovira, Anna;
    • Salar, Antonio;
    • Bastos, Mariana;
    • Gutiérrez, Antonio;
    • Bento, Leyre;
    • Córdoba, Raul;
    • Arquero, Teresa;
    • González de Villambrosia, Sonia;
    • Barranco, Gilberto;
    • De Oña, Raquel;
    • López Guillermo, Armando;
    • Rodriguez Salazar, María J.
    Publication type:
    Article
    3
    4
    5
    6

    Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 542, doi. 10.1111/bjh.15436
    By:
    • Vega‐García, Nerea;
    • Malatesta, Roberta;
    • Estella, Camino;
    • Pérez‐Jaume, Sara;
    • Esperanza‐Cebollada, Elena;
    • Torrebadell, Montserrat;
    • Català, Albert;
    • Gassiot, Susanna;
    • Berrueco, Rubén;
    • Ruiz‐Llobet, Anna;
    • Alonso‐Saladrigues, Anna;
    • Mesegué, Montserrat;
    • Pont‐Martí, Sandra;
    • Rives, Susana;
    • Camós, Mireia
    Publication type:
    Article
    7
    8
    9
    10
    11

    Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 504, doi. 10.1111/bjh.15421
    By:
    • Jones, Jeffrey;
    • Mato, Anthony;
    • Coutre, Steven;
    • Byrd, John C.;
    • Furman, Richard R.;
    • Hillmen, Peter;
    • Osterborg, Anders;
    • Tam, Constantine;
    • Stilgenbauer, Stephan;
    • Wierda, William G.;
    • Heerema, Nyla A.;
    • Eckert, Karl;
    • Clow, Fong;
    • Zhou, Cathy;
    • Chu, Alvina D.;
    • James, Danelle F.;
    • O'Brien, Susan M.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Issue Information.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 457, doi. 10.1111/bjh.14940
    Publication type:
    Article
    18
    20
    21

    NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 597, doi. 10.1111/bjh.14843
    By:
    • D'Agaro, Tiziana;
    • Bittolo, Tamara;
    • Bravin, Vanessa;
    • Dal Bo, Michele;
    • Pozzo, Federico;
    • Bulian, Pietro;
    • Rossi, Francesca M.;
    • Zucchetto, Antonella;
    • Degan, Massimo;
    • D'Arena, Giovanni;
    • Chiarenza, Annalisa;
    • Zaja, Francesco;
    • Pozzato, Gabriele;
    • Di Raimondo, Francesco;
    • Rossi, Davide;
    • Gaidano, Gianluca;
    • Del Poeta, Giovanni;
    • Gattei, Valter;
    • Bomben, Riccardo
    Publication type:
    Article
    22
    23
    24
    25

    Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2018, v. 182, n. 4, p. 583, doi. 10.1111/bjh.14820
    By:
    • Dang, Nam H.;
    • Ogura, Michinori;
    • Castaigne, Sylvie;
    • Fayad, Luis E.;
    • Jerkeman, Mats;
    • Radford, John;
    • Pezzutto, Antonio;
    • Bondarenko, Igor;
    • Stewart, Douglas A.;
    • Shnaidman, Michael;
    • Sullivan, Sharon;
    • Vandendries, Erik;
    • Tobinai, Kensei;
    • Ramchandren, Radhakrishnan;
    • Hamlin, Paul A.;
    • Giné, Eva;
    • Ando, Kiyoshi
    Publication type:
    Article
    26
    27